What is Royalty Pharma's operating lease liability payments due?

Royalty Pharma (RPRX) reported operating lease liability payments due of $21.16M in Q1 2026.

What does operating lease liability payments due mean?

The total future cash payments the company is contractually obligated to make for operating leases.

Discontinued — last reported Q3 '25

Operating Lease Liability Payments Due

Royalty Pharma Operating Lease Liability Payments Due decreased by 8.7% to $21.16M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionCurrent Liabilities

CategoryLiquidity

SignalLower is better

VolatilityStable

First reportedQ1 2019

Last reportedQ3 2025

How to read this metric

Rising liabilities indicate growing operational footprint or lease renewals, while falling liabilities may signal cost-cutting or consolidation of facilities.

Detailed definition

This represents the total future cash payments required for operating leases, typically categorized by maturity periods...

Peer comparison

Standardized under ASC 842, this metric is highly comparable across all public companies with significant physical operations.

Metric ID: operating_lease_liability_payments_due

Historical Data

3 periods

	Q2 '25	Q3 '25	Q1 '26
Value	$24.18M	$23.17M	$21.16M
QoQ Change	—	-4.2%	-8.7%

Range$21.16M – $24.18M

Current Streak2+ quarters decline

Frequently Asked Questions

What is Royalty Pharma's operating lease liability payments due?: Royalty Pharma (RPRX) reported operating lease liability payments due of $21.16M in Q1 2026.
What does operating lease liability payments due mean?: The total future cash payments the company is contractually obligated to make for operating leases.